Real-world experience of niraparib as maintenance therapy in newly diagnosed advanced ovarian cancer: A singlecenter retrospective study

被引：0
|
作者：
Wenxin, L. [1 ]
Wang, K. [1 ]
Zhang, L. [1 ]
Ma, Y. [1 ]
Wu, H. [1 ]
Chen, Y. [1 ]
Bao, L. [1 ]
Fu, X. [1 ]
机构：
[1] TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept Gynecol Oncol, Tianjin, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页码：S1594 / S1594
页数：1
相关论文
共 50 条
  • [31] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Cho, Angela
    Park, Jeong-Yeol
    Lee, Shin-Wha
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 304 (04) : 1055 - 1063
  • [32] Real-world experience of olaparib as maintenance therapy in BRCA-mutated recurrent ovarian cancer
    Angela Cho
    Jeong-Yeol Park
    Shin-Wha Lee
    Dae-Yeon Kim
    Dae-Shik Suh
    Jong-Hyeok Kim
    Yong-Man Kim
    Young-Tak Kim
    Archives of Gynecology and Obstetrics, 2021, 304 : 1055 - 1063
  • [33] Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer
    Salani, Ritu
    Boyle, Tirza Areli Calderon
    Lim, Jonathan
    Schilder, Jeanne M.
    Hurteau, Jean A.
    Perhanidis, Jessica
    Golembesky, Amanda
    Backes, Floor J.
    FUTURE ONCOLOGY, 2025, 21 (02) : 213 - 219
  • [34] Real-world experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive
    Roy, S.
    Ghosh, J.
    Bhattacharjee, A.
    Ganguly, S.
    Biswas, B.
    Patel, Y. S.
    Pal, S.
    Karmakar, J.
    Mishra, D.
    Vinarkar, S.
    Dey, I.
    Demde, R.
    Bhaumik, J.
    Ghosh, A.
    Chakraborti, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S1585 - S1585
  • [35] Evaluation of niraparib 200 mg/d as maintenance therapy in recurrent ovarian cancer and associated thrombocytopenia in a real-world US setting
    Thaker, P.
    Travers, K.
    Karki, C.
    Patel, R. P.
    Krebsbach, C.
    Harrow, B.
    Westin, S. N.
    ANNALS OF ONCOLOGY, 2019, 30 : 411 - 411
  • [36] Efficacy and safety of niraparib as first-line maintenance treatment for patients with advanced ovarian cancer: Real-world data from a multicenter study in China
    Shen, Yang
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S317 - S317
  • [37] Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
    Minmin Zhao
    Shanhu Qiu
    Xin Wu
    Pengcheng Miao
    Zhi Jiang
    Tao Zhu
    Xizhong Xu
    Yanling Zhu
    Bei Zhang
    Donglan Yuan
    Yang Zhang
    Wei Sun
    Aiqin He
    Min Zhao
    Wenjie Hou
    Yingli Zhang
    Zhuyan Shao
    Meiqun Jia
    Mei Li
    Jun Chen
    Jingcheng Xu
    Bingwei Chen
    Ying Zhou
    Yang Shen
    Targeted Oncology, 2023, 18 : 869 - 883
  • [38] How to start niraparib in real-world Asian ovarian cancer patients?
    Hong, Sook-Hee
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02)
  • [39] Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China
    Zhao, Minmin
    Qiu, Shanhu
    Wu, Xin
    Miao, Pengcheng
    Jiang, Zhi
    Zhu, Tao
    Xu, Xizhong
    Zhu, Yanling
    Zhang, Bei
    Yuan, Donglan
    Zhang, Yang
    Sun, Wei
    He, Aiqin
    Zhao, Min
    Hou, Wenjie
    Zhang, Yingli
    Shao, Zhuyan
    Jia, Meiqun
    Li, Mei
    Chen, Jun
    Xu, Jingcheng
    Chen, Bingwei
    Zhou, Ying
    Shen, Yang
    TARGETED ONCOLOGY, 2023, 18 (06) : 869 - 883
  • [40] Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Moore, K.
    Colombo, N.
    Scambia, G.
    Kim, B. -G.
    Oaknin, A.
    Friedlander, M.
    Lisyanskaya, A.
    Floquet, A.
    Leary, A.
    Sonke, G. S.
    Gourley, C.
    Banerjee, S.
    Oza, A.
    Gonzalez-Martin, A.
    Aghajanian, C.
    Bradley, W.
    Mathews, C.
    Liu, J.
    Lowe, E. S.
    Bloomfield, R.
    DiSilvestro, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2495 - 2505
12345